Independent Advisor Alliance cut its stake in shares of PetMed Express, Inc. (NASDAQ:PETS – Free Report) by 25.0% in the 4th quarter, HoldingsChannel.com reports. The firm owned 21,671 shares of the company’s stock after selling 7,220 shares during the quarter. Independent Advisor Alliance’s holdings in PetMed Express were worth $104,000 as of its most recent SEC filing.
Separately, R Squared Ltd acquired a new position in PetMed Express during the fourth quarter valued at approximately $31,000. Hedge funds and other institutional investors own 73.33% of the company’s stock.
Analysts Set New Price Targets
Separately, StockNews.com cut PetMed Express from a “buy” rating to a “hold” rating in a report on Tuesday, February 11th.
PetMed Express Stock Performance
PetMed Express stock opened at $4.04 on Friday. PetMed Express, Inc. has a 52 week low of $2.90 and a 52 week high of $6.85. The stock has a market capitalization of $83.45 million, a P/E ratio of 404.40 and a beta of 0.78. The stock has a 50-day simple moving average of $4.57 and a 200 day simple moving average of $4.48.
PetMed Express (NASDAQ:PETS – Get Free Report) last posted its quarterly earnings results on Monday, February 10th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.02). PetMed Express had a return on equity of 0.37% and a net margin of 0.14%. Research analysts forecast that PetMed Express, Inc. will post 0.19 earnings per share for the current year.
About PetMed Express
PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Further Reading
- Five stocks we like better than PetMed Express
- What Are Earnings Reports?
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- What Are Treasury Bonds?
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PetMed Express, Inc. (NASDAQ:PETS – Free Report).
Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.